Home > Healthcare > Medical Devices > Diagnostic Devices > Home Care Testing Market

Home Care Testing Market Analysis

  • Report ID: GMI10201
  • Published Date: Jul 2024
  • Report Format: PDF

Home Care Testing Market Analysis

Based on product type, the market is categorized into strip, cassette, test panel, midstream, dip card, and other product types. The strip segment dominated the market, with a revenue share of around 25.8% in 2023.

 

  • Strip-based tests are versatile and can be used for a wide range of applications, including pregnancy testing, monitoring blood glucose levels in diabetes, and testing for various infections or substances in urine. This versatility makes them appealing to a broad range of consumers with different healthcare needs?.

     

  • Additionally, strip tests are often more affordable compared to other types of home testing formats, making them accessible to a larger portion of the population, including those with limited financial resources, resulted in their increased demand.

     

Based on test type, the home care testing market is categorized into infectious disease, diabetes & glucose, HIV, pregnancy, cholesterol & triglycerides, urinary tract infection, and other test types. The infectious disease segment is anticipated to witness highest growth with USD 5.2 billion in 2032.

 

  • Rapid home testing kits for infectious diseases provide quick results, allowing individuals to receive timely information about their health status. This is crucial for early detection and containment of infectious diseases.

     

  • Additionally, integration with telehealth services allows individuals to consult healthcare professionals remotely, further enhancing the value of home testing for infectious diseases. Hence these factors contributed to the segmental growth.

     

Based on sample, the home care testing market is categorized into blood, urine, saliva, and other samples. The blood segment dominated the market, with a revenue share of 40.7% in 2023.

 

  • Blood samples are used for a wide range of diagnostic tests, including glucose monitoring for diabetes, cholesterol testing, infectious disease screening, and hormone level assessments, among others. This broad applicability makes blood-based home testing kits relevant to a large segment of the population.

     

  • Additionally, blood-based tests are often considered more clinically accurate compared to other sample types. This accuracy is crucial for medical conditions that require precise measurement and monitoring, further driving the demand for blood-based home testing kits.

 

Home Care Testing Market, By Distribution Channel (2023)

Based on distribution channel, the home care testing market is categorized into retail pharmacies, hospital pharmacies, online pharmacies and other distribution channel. The retail pharmacies segment dominated the market, with a revenue share of around 39.1% in 2023.

 

  • Retail pharmacies have a wide network of outlets, making them easily accessible to a large population, including individuals seeking home care testing solutions.

     

  • Additionally, retail pharmacies generally maintain sufficient inventory levels of home care testing kits, ensuring that products are readily available for purchase. This immediate availability meets the needs of consumers who require testing kits on short notice or prefer to obtain them without delay.

 

North America Home Care Testing Market, 2021- 2032 (USD Billion)

North America home care testing market accounted for USD 4.9 billion revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.

 

  • The increasing incidence of chronic diseases such as diabetes, hypertension, and cardiovascular conditions necessitates regular monitoring, which home care testing effectively facilitates. For instance, the American Diabetes Association reports that over 34 million Americans have diabetes, driving the demand for home glucose monitoring.

     

  • Additionally, North America is at the forefront of technological advancements, with the development of sophisticated home testing devices, which increases their demand in the region.

     

U.S. home care testing market holds a dominant position with the market share of 93.8% in 2023.

 

  • The U.S. Food and Drug Administration (FDA) has approved a growing number of home testing kits, providing consumers with assurance regarding safety and reliability.

     

  • Additionally, government and public health initiatives in the U.S. promote preventive care and early detection, aligning with the goals of home testing for chronic conditions and infectious diseases, increased their demand in the country.

     

Germany home care testing market is expected to grow significantly during the forecast period.

 

  • There is a growing emphasis on preventive healthcare in Germany, with individuals increasingly interested in monitoring their health proactively through home testing.

     

  • Additionally, home testing addresses issues of healthcare accessibility, particularly in rural or remote areas of Germany where access to healthcare facilities may be limited. Hence contributes to the market growth in Germany.

     

China home care testing market is anticipated to witness a high growth rate from 2024-2032, due to several factors.

 

  • As China economy continues to grow, there has been an increase in healthcare spending, driving demand for convenient and affordable healthcare solutions like home testing.

     

  • Additionally, the Chinese government has been promoting preventive healthcare and encouraging innovation in the healthcare sector, which includes support for home testing technologies.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Home care testing market size was valued at USD 10.9 billion in 2023 and is estimated to grow at 6.8% CAGR from 2024 to 2032, driven by the rising prevalence of chronic diseases.

The strip segment held a 25.8% revenue share in 2023 and will grow rapidly through 2032, owing to its versatility.

North America home care testing market size was USD 4.9 billion in 2023 and is predicted to witness substantial market growth through 2032, driven by the increasing incidence of chronic diseases, such as diabetes, hypertension, and cardiovascular conditions.

Chembio Diagnostics, Inc, F. Hoffmann-La Roche Ltd., LifeScan IP Holdings, LLC, MP BIOMEDICALS, Nova Biomedical, OraSure Technologies, Inc., Quidel Corp, SA Scientific Ltd, Siemens Healthcare GmbH, and Sterilab Services among others.

Home Care Testing Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 17
  • Tables & Figures: 151
  • Countries covered: 23
  • Pages: 100
 Download Free Sample